vTv Therapeutics Inc (VTVT)

[airahim]

On December 27, 2018, vTv Therapeutics Inc. (the “Company”) exercised its right to cause MacAndrews & Forbes Group LLC (the “Investor”) to purchase 815,217 shares of the Company’s Class A common stock at a per share price of $1.84 pursuant to the terms of the letter agreement between the Company and the Investor dated December 11, 2018 (the “December 2018 Letter Agreement”). The Investor funded $1.5 million to the Company in exchange for 815,217 shares of Class A common stock following the execution of definitive documentation by and between the Company and the Investor.